OrbiMed Capital GP VII LLC (CIK 0001760648)

Latest company ownership

Shares held
7,663,349
Last filed at
May 20, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q1 2025Q4
PASG - Passage BIO, Inc.
Role: 10% Owner
Shares held
6,066,343
Last filed at
Jun 26, 2025
Confidence Score
46.9
2025Q4
Confidence Score History
2020Q1 2025Q4
GLTO - Galecto, Inc.
Role: 10% Owner
Shares held
1,510,375
Last filed at
Aug 17, 2023
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q4 2025Q4
Shares held
755,635
Last filed at
Jul 17, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q1 2025Q4
Shares held
747,887
Last filed at
Feb 19, 2025
Confidence Score
50.5
2025Q4
Confidence Score History
2024Q3 2025Q4
Shares held
415,142
Last filed at
Jun 28, 2022
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q1 2025Q4
Shares held
245,898
Last filed at
Dec 17, 2021
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q4 2025Q4
Shares held
119,522
Last filed at
Aug 15, 2024
Confidence Score
25.6
2025Q4
Confidence Score History
2020Q2 2025Q4
Shares held
96,190
Last filed at
Sep 8, 2021
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Nov 21, 2025 Dec 18, 2025 Keros Therapeutics, Inc. Director Sell 17.5 -214,522 -21.06% ✗ $3.8M
Jun 24, 2025 Jun 26, 2025 Passage BIO, Inc. 10% Owner Sell 22.5 -583,657 -8.78% ✗ $197.2K
Apr 22, 2025 Apr 24, 2025 Passage BIO, Inc. 10% Owner Sell 22.5 -235,572 -3.42% ✗ $78.7K
Apr 15, 2025 Apr 17, 2025 Passage BIO, Inc. 10% Owner Sell 26.3 -149,054 -2.12% ✗ $49.7K
Feb 14, 2025 Feb 19, 2025 MBX Biosciences, Inc. Director Buy 87.5 +190,672 1.87% ✗ $2M
Jan 10, 2025 Jan 14, 2025 Passage BIO, Inc. 10% Owner Sell 22.5 -223,219 -3.08% ✗ $142.2K
Jan 6, 2025 Jan 8, 2025 Passage BIO, Inc. 10% Owner Sell 22.5 -147,024 -1.99% ✗ $103.3K
Dec 20, 2024 Dec 26, 2024 Passage BIO, Inc. 10% Owner Sell 22.5 -230,321 -3.02% ✗ $138.2K
Dec 9, 2024 Dec 11, 2024 Passage BIO, Inc. 10% Owner Sell 32.5 -62,276 -0.81% ✗ $52K
Dec 4, 2024 Dec 6, 2024 Passage BIO, Inc. 10% Owner Sell 22.5 -97,103 -1.25% ✗ $77.3K
Sep 19, 2024 Sep 23, 2024 Passage BIO, Inc. 10% Owner Sell 36.3 -39,300 -0.50% ✗ $27.9K
Sep 16, 2024 Sep 18, 2024 Passage BIO, Inc. 10% Owner Sell 22.5 -200,131 -2.49% ✗ $146.7K
Sep 16, 2024 Sep 17, 2024 MBX Biosciences, Inc. Director Buy 100.0 +750,000 24.49% ✗ $12M
Aug 13, 2024 Aug 15, 2024 Keros Therapeutics, Inc. Director Sell 15.0 -250,000 -19.70% ✗ $11M
Jul 15, 2024 Jul 17, 2024 Terns Pharmaceuticals, Inc. Director Sell 37.5 -56,164 -0.37% ✗ $561.6K
May 16, 2024 May 20, 2024 Enliven Therapeutics, Inc. Director Sell 15.0 -1,033,300 -11.54% ✗ $22.9M
Aug 15, 2023 Aug 17, 2023 Galecto, Inc. 10% Owner Sell 20.0 -822,680 -26.87% ✗ $617K
Jul 31, 2023 Aug 2, 2023 Galecto, Inc. 10% Owner Sell 20.0 -209,400 -6.29% ✗ $628.2K
Jul 25, 2023 Jul 27, 2023 Galecto, Inc. 10% Owner Sell 22.5 -39,200 -1.16% ✗ $114.5K
Jul 13, 2023 Jul 17, 2023 Galecto, Inc. 10% Owner Sell 20.0 -194,700 -5.46% ✗ $467.3K
Jun 27, 2023 Jun 29, 2023 Passage BIO, Inc. 10% Owner Buy 100.0 +1,192,577 17.43% ✗ $1M
Apr 13, 2023 Apr 17, 2023 Galecto, Inc. 10% Owner Sell 32.5 -68,481 -0.63% ✗ $128.3K
Apr 10, 2023 Apr 12, 2023 Galecto, Inc. 10% Owner Sell 32.5 -67,537 -0.61% ✗ $121.4K
Apr 5, 2023 Apr 7, 2023 Galecto, Inc. 10% Owner Sell 22.5 -102,630 -1.37% ✗ $222K
Dec 23, 2022 Dec 28, 2022 Terns Pharmaceuticals, Inc. Director Buy 90.0 +137,931 2.91% ✗ $1000K
Aug 16, 2022 Aug 18, 2022 Terns Pharmaceuticals, Inc. Director Buy 100.0 +3,690,000 97.33% ✗ $8.9M
Jun 24, 2022 Jun 28, 2022 Arcutis Biotherapeutics, Inc. 10% Owner Sell 16.3 -341,971 -7.97% ✗ $7.3M
May 3, 2022 May 5, 2022 Passage BIO, Inc. 10% Owner Buy 95.0 +525,000 8.31% ✗ $1M
Jan 20, 2022 May 5, 2022 Passage BIO, Inc. 10% Owner Buy 75.0 +50,800 0.81% ✗ $254K
Apr 6, 2022 Apr 8, 2022 Arcutis Biotherapeutics, Inc. 10% Owner Sell 15.0 -878,200 -6.06% ✗ $18.2M
Jan 20, 2022 Jan 24, 2022 Passage BIO, Inc. 10% Owner Buy 95.0 +369,100 5.89% ✗ $2M
Jan 14, 2022 Jan 20, 2022 Passage BIO, Inc. 10% Owner Buy 90.0 +168,300 2.76% ✗ $905.2K
Jan 11, 2022 Jan 13, 2022 Passage BIO, Inc. 10% Owner Buy 90.0 +150,000 2.52% ✗ $841.1K
Dec 16, 2021 Dec 17, 2021 Janux Therapeutics, Inc. Director Sell 16.3 -393,300 -12.93% ✗ $7.5M
Sep 3, 2021 Sep 8, 2021 Repare Therapeutics Inc. Director Sell 47.5 -8,084 -0.12% ✓ $274.8K
Aug 31, 2021 Sep 2, 2021 Repare Therapeutics Inc. Director Sell 43.8 -37,864 -0.38% ✓ $1.3M
Aug 26, 2021 Aug 30, 2021 Repare Therapeutics Inc. Director Sell 47.5 -18,073 -0.18% ✓ $615.7K
Aug 23, 2021 Aug 25, 2021 Repare Therapeutics Inc. Director Sell 47.5 -18,215 -0.18% ✓ $622.4K
Aug 17, 2021 Aug 19, 2021 Repare Therapeutics Inc. Director Sell 46.3 -20,328 -0.30% ✓ $693.2K
Jul 16, 2021 Jul 23, 2021 Enliven Therapeutics, Inc. Director Buy 100.0 +1,666,666 65.81% ✗ $10M
Jul 16, 2021 Jul 16, 2021 Enliven Therapeutics, Inc. Director Buy 100.0 +1,666,666 100.00% ✗ $10M
Feb 9, 2021 Feb 9, 2021 Terns Pharmaceuticals, Inc. Director Buy 100.0 +475,000 14.32% ✗ $8.1M
Nov 2, 2020 Nov 4, 2020 Galecto, Inc. Director Buy 100.0 +733,333 25.48% ✗ $11M
Oct 2, 2020 Oct 6, 2020 Arcutis Biotherapeutics, Inc. Director Buy 100.0 +496,000 10.61% ✗ $12.4M
Jun 23, 2020 Jun 25, 2020 Repare Therapeutics Inc. Director Buy 100.0 +774,200 29.76% ✗ $15.5M
Apr 13, 2020 Apr 13, 2020 Keros Therapeutics, Inc. Director Buy 100.0 +375,200 50.39% ✗ $6M
Mar 12, 2020 Mar 16, 2020 Enliven Therapeutics, Inc. Director Buy 100.0 +937,500 100.00% ✗ $15M
Feb 28, 2020 Mar 3, 2020 Passage BIO, Inc. 10% Owner Buy 100.0 +373,300 100.00% ✗ $6.7M
Feb 3, 2020 Feb 4, 2020 Arcutis Biotherapeutics, Inc. Director Buy 100.0 +558,888 100.00% ✗ $9.5M